Evidence map›Paper›PMID 40010991›Full record

ArticleIn vivo (Athens, Greece)

Enhancing Patient-specific Quality Assurance in Carbon-ion Radiation Therapy: Recalculating Delivered Dose Distribution Using Log Data.

Yongdo Yun, Min Cheol Han, Changhwan Kim, Chae-Seon Hong, Dong Wook Kim, H O Lee, Hojin Kim, Soorim Han, Hikaru Souda, Sung Hyun Lee and 3 more

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yongdo YunDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Min Cheol HanDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; mchan@yuhs.ac.
Changhwan KimDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Chae-Seon HongDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Dong Wook KimDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
H O LeeDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hojin KimDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Soorim HanDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hikaru SoudaDepartment of Heavy Particle Medical Science, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
Sung Hyun LeeDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Yuya MiyasakaDepartment of Heavy Particle Medical Science, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
Takeo IwaiDepartment of Heavy Particle Medical Science, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
Jin Sung KimDepartment of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; jinsung@yuhs.ac.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimLog data from radiation treatment machines can play a crucial role in quality assurance by enabling the recalculation of the delivered dose distribution and identification of deviations in treatment delivery. This article proposes a novel method for recalculating the delivered dose distribution in carbon-ion radiation therapy using log data. MATERIALS AND

methodsThe proposed approach leverages existing functionality in commercial treatment planning systems, thus eliminating the need for specialized in-house software for dose calculation and evaluation. The performed tests entail data generation from actual log files using the Digital Imaging and Communications in Medicine standard, biological dose calculations, and gamma evaluations.

resultsThe log-based approach demonstrated notable advantages, including improved time efficiency and the ability to calculate three-dimensional biological doses. By recalculating the delivered dose distributions, our method improves quality assurance accuracy in carbon-ion radiation therapy. It complements conventional measurement-based patient-specific quality assurance methods, serving as a valuable addition to the arsenal of tools available for treatment evaluation.

conclusionWe believe that our method has the potential to enhance the efficacy of patient-specific quality assurance and contribute significantly to the advancement of carbon-ion radiation therapy, thereby reinforcing the ongoing evolution of particle therapy.

Indexed as

Heavy Ion RadiotherapyNeoplasmsQuality Assurance, Health CareRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosageSoftwarebiological dose distributionCarbon-ion radiation therapylog datapatient-specific quality assurancetreatment planning system

Identifiers

PMID40010991
PMCPMC11884496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.